Oncolytics Biotech : Condensed Interim Consolidated Financial Statements

Condensed Interim Consolidated Financial Statements








Oncolytics Biotech® Inc.


For the threeandsix months ended June 30, 2023
...
-Today at 09:53 am- MarketScreener

Related Keywords

Canada ,Ukraine ,United States ,Germany ,Toronto ,Ontario ,Canadian , ,Toronto Stock Exchange ,Pfizer Inc ,Canaccord Genuity Inc ,Our Base Shelf ,International Accounting Standard ,International Financial Reporting Standards ,Oncolytics Biotech ,Merck Kga ,Party Transactions ,Oncolytics Biotech Us Inc ,Merck Kgaa ,Oncolytics Biotech Inc ,Alberta Ltd ,Oncolytics Biotech Barbados Inc ,International Accounting Standards Board ,A Base Shelf ,Pfizer ,Shareholder Equity ,Months Ended June ,Business Corporations Act ,Nasdaq Capital Market ,Toronto Stock ,Financial Reporting ,Material Accounting Policies ,New Accounting Standards ,Financial Statements ,Materiality Judgements ,Accounting Estimates ,Balance Sheet Details ,Share Capital ,Canaccord Genuity ,Share Based Compensation ,Stock Option Plan ,Share Award Plan ,Equity Incentive Plans ,Equity Incentive ,Exercise Prices ,Average Remaining Contractual Life ,Loss Per Common Share ,Capital Disclosures ,Base Shelf ,Financial Instruments ,Additional Cash Flow Disclosures ,Related Party Transactions ,Key Management Personnel ,Executive Officers ,Subsequent Events ,Markets ,